| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Feb 25 | ALLO Allogene Therapeutics | Common Stock | Sell | Dispose S | No | No | 1.71 | 14,746 | 25.22 k | 250,713 |
| 5 Jun 24 | CERS Cerus | Common Stock | Grant | Acquire A | No | No | 5 | 40,000 | 200.00 k | 145,073 |
| 22 Apr 24 | ALLO Allogene Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 3.4671 | 17,360 | 60.19 k | 265,459 |
| 8 Mar 24 | BLFS BioLife Solutions | Common Stock | Grant | Acquire A | No | No | 0 | 11,264 | 0.00 | 29,897 |
| 25 Jan 24 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 96,600 | 0.00 | 282,819 |
| 25 Jan 24 | ALLO Allogene Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.2 | 341,515 | 1.09 mm | 341,515 |
